Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

263.12
Delayed Data
As of May 04
 -10.59 / -3.87%
Today’s Change
242.07
Today|||52-Week Range
420.99
-14.11%
Year-to-Date

Today’s Trading

Previous close273.71
Today’s open271.70
Day’s range262.44 - 271.75
Volume1,788,237
Average volume (3 months)1,849,992
Market cap$60.0B
Dividend yield--
Data as of 4:00pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+10.72%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-3.87%
P/E ratio16.2
Price/Sales7.60
Price/Book6.38

Competitors

 Today’s
change
Today’s
% change
BXLTBaxalta Inc-0.91-2.15%
BAXBaxter International...+0.73+1.64%
JUNOJuno Therapeutics In...-1.30-3.28%
CTLTCatalent Inc-0.11-0.37%
Data as of 4:01pm ET, 05/04/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$4.58
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs